Theodora Papadopoulou

Theodora Papadopoulou

Auto-generated profile, based on publicly available information

Theodora Papadopoulou

ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in Science Advances
Verified
Journal Article
Open access
MSMara Suleiman
Mara Suleiman
TSToshiaki Sawatani
Toshiaki Sawatani
MTMarta Tesi
Marta Tesi
XYXiaoyan Yi
Xiaoyan Yi
TPTheodora Papadopoulou
Theodora Papadopoulou
LMLorella Marselli
Lorella Marselli
Remission of type 2 diabetes (T2D) can occur after hypocaloric diet, bariatric surgery, or pharmacological treatments and associates with improved β cell function. Here, we studied islets from nondiabetic ( n = 15) and T2D ( n = 21) donors. We examined whether T2D β cell dysfunction can be rescued, charted the underlying molecular mechanisms by RNA sequencing, and mined transcriptomes for drug targets. Glucose responsiveness of T2D β cells improved in 60% of preparations after 3-day culture in euglycemic conditions. This was accompanied by changes in expression of >400 genes involved in functional or inflammatory pathways. Drug repurposing and target identification analyses predicted chemical and genetic hits, including JAK inhibitors, which were validated in a β cell line, human islets, and db/db mice. Therefore, defective β cell glucose responsiveness in T2D can recover, demonstrating β cell functional plasticity. The recovery associates with transcriptomic traits, pointing to targetable defects to induce T2D remission.

23 July 2026 in STAR Protocols
Verified
Journal Article
Open access
TPTheodora Papadopoulou
Theodora Papadopoulou
ASAristeidis Sionakidis
Aristeidis Sionakidis
APAnthony Piron
Anthony Piron
MCMiriam Cnop
Miriam Cnop